Details for New Drug Application (NDA): 207761
✉ Email this page to a colleague
The generic ingredient in NADOLOL is bendroflumethiazide; nadolol. There are four drug master file entries for this compound. Additional details are available on the bendroflumethiazide; nadolol profile page.
Summary for 207761
Tradename: | NADOLOL |
Applicant: | Zydus Pharms |
Ingredient: | nadolol |
Patents: | 0 |
Pharmacology for NDA: 207761
Mechanism of Action | Adrenergic beta-Antagonists |
Medical Subject Heading (MeSH) Categories for 207761
Suppliers and Packaging for NDA: 207761
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
NADOLOL | nadolol | TABLET;ORAL | 207761 | ANDA | Zydus Pharmaceuticals USA Inc. | 68382-732 | 68382-732-01 | 100 TABLET in 1 BOTTLE (68382-732-01) |
NADOLOL | nadolol | TABLET;ORAL | 207761 | ANDA | Zydus Pharmaceuticals USA Inc. | 68382-732 | 68382-732-10 | 1000 TABLET in 1 BOTTLE (68382-732-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 20MG | ||||
Approval Date: | Jul 28, 2017 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 40MG | ||||
Approval Date: | Jul 28, 2017 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 80MG | ||||
Approval Date: | Jul 28, 2017 | TE: | AB | RLD: | No |
Complete Access Available with Subscription